Chemed (CHE) Equity Average (2010 - 2026)

Chemed (CHE) has reported Equity Average for 17 consecutive years, with $913.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Average fell 20.57% year-over-year to $913.7 million; the TTM figure through Mar 2026 stood at $913.7 million (down 20.57% YoY), while the FY2025 annual figure was $1.0 billion, down 5.77% from the prior year.
• Equity Average came in at $913.7 million for Q1 2026 at Chemed, down from $1.0 billion in the prior quarter.
• The five-year high for Equity Average was $1.2 billion in Q3 2024, with the low at $645.0 million in Q1 2022.
• Average Equity Average over 5 years is $985.2 million, with a median of $1.0 billion recorded in 2025.
• Across the five-year window, Equity Average declined 29.51% in 2022 and jumped 40.17% in 2023, its largest moves.
• Year by year, Equity Average stood at $760.1 million in 2022, then jumped by 39.93% to $1.1 billion in 2023, then rose by 10.7% to $1.2 billion in 2024, then retreated by 12.68% to $1.0 billion in 2025, then dropped by 11.12% to $913.7 million in 2026.
• According to Business Quant data, Equity Average over the past three periods registered $913.7 million, $1.0 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.